J. Alvar, I. Velez, C. Bern, M. Herrero, and P. Desjeux, Leishmaniasis Worldwide and Global Estimates of Its Incidence, PLoS ONE, vol.83, issue.30, p.22693548, 2012.
DOI : 10.1371/journal.pone.0035671.s101

P. Bates, Transmission of Leishmania metacyclic promastigotes by phlebotomine sand flies, International Journal for Parasitology, vol.37, issue.10, pp.1097-1106, 2007.
DOI : 10.1016/j.ijpara.2007.04.003

M. Rogers, M. Hajmova, M. Joshi, J. Sadlova, and D. Dwyer, Leishmania chitinase facilitates colonization of sand fly vectors and enhances transmission to mice, Cellular Microbiology, vol.30, issue.6, pp.1363-1372, 2008.
DOI : 10.1111/j.1550-7408.1993.tb04904.x

D. Sacks and S. Kamhawi, Molecular Aspects of Parasite-Vector and Vector-Host Interactions in Leishmaniasis, Annual Review of Microbiology, vol.55, issue.1, pp.453-483, 2001.
DOI : 10.1146/annurev.micro.55.1.453

F. Chappuis, S. Sundar, A. Hailu, H. Ghalib, and S. Rijal, Visceral leishmaniasis: what are the needs for diagnosis, treatment and control?, Nature Reviews Microbiology, vol.14, issue.11, pp.873-882, 2007.
DOI : 10.1038/nrmicro1748

F. Dantas-torres, L. Solano-gallego, G. Baneth, V. Ribeiro, and M. De-paiva-cavalcanti, Canine leishmaniosis in the Old and New Worlds: unveiled similarities and differences, Trends in Parasitology, vol.28, issue.12, pp.531-538, 2012.
DOI : 10.1016/j.pt.2012.08.007

I. Mauricio, J. Stothard, and M. Miles, The Strange Case of Leishmania chagasi, Parasitology Today, vol.16, issue.5, pp.188-189, 2000.
DOI : 10.1016/S0169-4758(00)01637-9

J. Rioux and G. Lanotte, Leishmania infantum as a cause of cutaneous leishmaniasis, Transactions of the Royal Society of Tropical Medicine and Hygiene, vol.84, issue.6, p.898, 1990.
DOI : 10.1016/0035-9203(90)90120-4

K. Evans and L. Kedzierski, Development of Vaccines against Visceral Leishmaniasis, Journal of Tropical Medicine, vol.179, issue.5, p.21912561, 2012.
DOI : 10.1111/j.1365-3024.2008.01020.x

M. Harhay, P. Olliaro, D. Costa, and C. Costa, Urban parasitology: visceral leishmaniasis in Brazil, Trends in Parasitology, vol.27, issue.9, pp.403-409, 2011.
DOI : 10.1016/j.pt.2011.04.001

C. Palatnik-de-sousa, Vaccines for Canine Leishmaniasis, Frontiers in Immunology, vol.3, p.22566950, 2012.
DOI : 10.3389/fimmu.2012.00069

C. Palatnik-de-sousa and M. Day, One Health: The global challenge of epidemic and endemic leishmaniasis, Parasites & Vectors, vol.4, issue.1, p.21985335, 2011.
DOI : 10.1016/S0140-6736(02)09609-5

G. Romero and M. Boelaert, Control of Visceral Leishmaniasis in Latin America???A Systematic Review, PLoS Neglected Tropical Diseases, vol.41, issue.14, 2010.
DOI : 10.1371/journal.pntd.0000584.s001

L. Athanasiou, V. Kontos, M. Saridomichelakis, T. Rallis, and A. Diakou, A cross-sectional sero-epidemiological study of canine leishmaniasis in Greek mainland, Acta Tropica, vol.122, issue.3, pp.291-295, 2012.
DOI : 10.1016/j.actatropica.2012.02.003

K. Rock, E. Le-rutte, S. De-vlas, E. Adams, and G. Medley, Uniting mathematics and biology for control of visceral leishmaniasis, Trends in Parasitology, vol.31, issue.6, pp.251-259, 2015.
DOI : 10.1016/j.pt.2015.03.007

G. Bongiorno, R. Paparcone, F. Manzillo, V. Oliva, G. Cuisinier et al., Vaccination with LiESP/QA-21 (CaniLeish??) reduces the intensity of infection in Phlebotomus perniciosus fed on Leishmania infantum infected dogs???A preliminary xenodiagnosis study, Veterinary Parasitology, vol.197, issue.3-4, pp.691-695, 2013.
DOI : 10.1016/j.vetpar.2013.05.008

F. Modabber, Vaccines against leishmaniasis, Annals of Tropical Medicine & Parasitology, vol.145, issue.sup1, pp.83-88, 1995.
DOI : 10.1016/0166-6851(94)90057-4

S. Ajdary, M. Alimohammadian, M. Eslami, K. Kemp, and A. Kharazmi, Comparison of the Immune Profile of Nonhealing Cutaneous Leishmaniasis Patients with Those with Active Lesions and Those Who Have Recovered from Infection, Infection and Immunity, vol.68, issue.4, pp.1760-1764, 2000.
DOI : 10.1128/IAI.68.4.1760-1764.2000

E. Carvalho, C. Filho, D. Bacellar, O. Almeida, R. Lessa et al., Characterization of the immune response in subjects with self-healing cutaneous leishmaniasis, Am J Trop Med Hyg, vol.53, pp.273-277, 1995.

A. Kharazmi, K. Kemp, A. Ismail, S. Gasim, and A. Gaafar, T-cell response in human leishmaniasis, Immunology Letters, vol.65, issue.1-2, pp.105-108, 1999.
DOI : 10.1016/S0165-2478(98)00132-1

A. Sassi, H. Louzir, B. Salah, A. Mokni, M. et al., Leishmanin skin test lymphoproliferative responses and cytokine production after symptomatic or asymptomatic Leishmania major infection in Tunisia, Clinical and Experimental Immunology, vol.62, issue.1, pp.127-132, 1999.
DOI : 10.1084/jem.174.5.1209
URL : https://hal.archives-ouvertes.fr/pasteur-00878412

G. Bourdoiseau, C. Hugnet, R. Goncalves, F. Vezilier, and E. Petit-didier, Effective humoral and cellular immunoprotective responses in Li ESAp-MDP vaccinated protected dogs, Veterinary Immunology and Immunopathology, vol.128, issue.1-3, pp.71-78, 2009.
DOI : 10.1016/j.vetimm.2008.10.309

G. Bourdoiseau, C. Hugnet, G. Papierok, and J. Lemesre, Canine leishmaniosis due to Leishmania infantum:immunotherapy trials, Bull Acad Vet France, vol.157, pp.63-67, 2004.

R. Chamakh-ayari, R. Bras-goncalves, N. Bahi-jaber, E. Petitdidier, and W. Markikou-ouni, In Vitro Evaluation of a Soluble Leishmania Promastigote Surface Antigen as a Potential Vaccine Candidate against Human Leishmaniasis, PLoS ONE, vol.39, issue.5, p.24786587, 2014.
DOI : 10.1371/journal.pone.0092708.t003
URL : https://hal.archives-ouvertes.fr/pasteur-01060485

P. Holzmuller, M. Cavaleyra, J. Moreaux, R. Kovacic, and P. Vincendeau, Lymphocytes of dogs immunised with purified excreted-secreted antigens of Leishmania infantum co-incubated with Leishmania infected macrophages produce IFN gamma resulting in nitric oxide-mediated amastigote apoptosis, Veterinary Immunology and Immunopathology, vol.106, issue.3-4, pp.247-257, 2005.
DOI : 10.1016/j.vetimm.2005.03.001

C. Hugnet, J. Lemesre, G. Papierok, and G. Bourdoiseau, Results of vaccination against canine visceral leishmaniasis (Leishmania infantum) in enzootic areas, Bull Acad Vet France, vol.159, pp.127-130, 2006.

J. Lemesre, P. Holzmuller, M. Cavaleyra, R. Goncalves, and G. Hottin, Protection against experimental visceral leishmaniasis infection in dogs immunized with purified excreted secreted antigens of Leishmania infantum promastigotes, Vaccine, vol.23, issue.22, pp.2825-2840, 2005.
DOI : 10.1016/j.vaccine.2004.11.061

J. Lemesre, P. Holzmuller, R. Goncalves, G. Bourdoiseau, and C. Hugnet, Long-lasting protection against canine visceral leishmaniasis using the LiESAp-MDP vaccine in endemic areas of France: Double-blind randomised efficacy field trial, Vaccine, vol.25, issue.21, pp.4223-4234, 2007.
DOI : 10.1016/j.vaccine.2007.02.083

T. Merlen, D. Sereno, N. Brajon, F. Rostand, and J. Lemesre, Leishmania spp: completely defined medium without serum and macromolecules (CDM/LP) for the continuous in vitro cultivation of infective promastigote forms, Am J Trop Med Hyg, vol.60, pp.41-50, 1999.

G. Oliva, J. Nieto, F. Manzillo, V. Cappiello, S. Fiorentino et al., A Randomised, Double-Blind, Controlled Efficacy Trial of the LiESP/QA-21 Vaccine in Na??ve Dogs Exposed to Two Leishmania infantum Transmission Seasons, PLoS Neglected Tropical Diseases, vol.25, issue.10, p.25299614, 2014.
DOI : 10.1371/journal.pntd.0003213.g010

L. Gradoni, Canine Leishmania vaccines: Still a long way to go, Veterinary Parasitology, vol.208, issue.1-2, p.25620293, 2015.
DOI : 10.1016/j.vetpar.2015.01.003

R. Goncalves, E. Petitdidier, J. Pagniez, R. Veyrier, and P. Cibrelus, Identification and characterization of new Leishmania promastigote surface antigens, LaPSA-38S and LiPSA-50S, as major immunodominant excreted/secreted components of L. amazonensis and L. infantum, Excreted/Secreted PSA Protection in Dogs PLOS Neglected Tropical Diseases | DOI:10.1371, pp.1-14, 2014.

A. Devault and A. Banuls, The promastigote surface antigen gene family of the Leishmania parasite: differential evolution by positive selection and recombination, BMC Evolutionary Biology, vol.8, issue.1, p.18950494, 2008.
DOI : 10.1186/1471-2148-8-292

A. Jimenez-ruiz, C. Boceta, P. Bonay, J. Requena, and C. Alonso, Cloning, sequencing, and expression of the PSA genes from Leishmania infantum, European Journal of Biochemistry, vol.251, issue.1-2, pp.389-397, 1998.
DOI : 10.1046/j.1432-1327.1998.2510389.x

D. Mcmahon-pratt, Y. Traub-cseko, K. Lohman, D. Rogers, and S. Beverley, Loss of the GP46/M-2 surface membrane glycoprotein gene family in the Leishmania braziliensis complex, Molecular and Biochemical Parasitology, vol.50, issue.1, pp.151-160, 1992.
DOI : 10.1016/0166-6851(92)90252-F

F. Symons, P. Murray, J. H. Simpson, R. Osborn, and A. , Characterization of a polymorphic family of integral membrane proteins in promastigotes of different Leishmania species, Molecular and Biochemical Parasitology, vol.67, issue.1, pp.103-113, 1994.
DOI : 10.1016/0166-6851(94)90100-7

J. Webb, A. Campos-neto, P. Ovendale, T. Martin, and E. Stromberg, Human and murine immune responses to a novel Leishmania major recombinant protein encoded by members of a multicopy gene family, Infect Immun, vol.66, pp.3279-3289, 1998.

L. Kedzierski, J. Montgomery, D. Bullen, C. J. Gardiner, and E. , A Leucine-Rich Repeat Motif of Leishmania Parasite Surface Antigen 2 Binds to Macrophages through the Complement Receptor 3, The Journal of Immunology, vol.172, issue.8, pp.4902-4906, 2004.
DOI : 10.4049/jimmunol.172.8.4902

L. Lincoln, M. Ozaki, J. Donelson, and J. Beetham, Genetic complementation of Leishmania deficient in PSA (GP46) restores their resistance to lysis by complement, Molecular and Biochemical Parasitology, vol.137, issue.1, pp.185-189, 2004.
DOI : 10.1016/j.molbiopara.2004.05.004

E. Handman, F. Symons, T. Baldwin, J. Curtis, and J. Scheerlinck, Protective vaccination with promastigote surface antigen 2 from Leishmania major is mediated by a TH1 type of immune response, Infect Immun, vol.63, pp.4261-4267, 1995.

K. Lohman, P. Langer, and D. Mcmahon-pratt, Molecular cloning and characterization of the immunologically protective surface glycoprotein GP46/M-2 of Leishmania amazonensis., Proceedings of the National Academy of Sciences, vol.87, issue.21, pp.8393-8397, 1990.
DOI : 10.1073/pnas.87.21.8393

A. Das and N. Ali, Vaccine Development Against Leishmania donovani, Frontiers in Immunology, vol.3, p.22615707, 2012.
DOI : 10.3389/fimmu.2012.00099

F. Modabber, Leishmaniasis vaccines: past, present and future, International Journal of Antimicrobial Agents, vol.36, 2010.
DOI : 10.1016/j.ijantimicag.2010.06.024

G. Borja-cabrera, F. Santos, F. Santos, F. Trivellato, and J. Kawasaki, Immunotherapy with the saponin enriched-Leishmune?? vaccine versus immunochemotherapy in dogs with natural canine visceral leishmaniasis, Vaccine, vol.28, issue.3, pp.597-603, 2010.
DOI : 10.1016/j.vaccine.2009.09.071

E. Oliveira-freitas, C. Casas, G. Borja-cabrera, F. Santos, and D. Nico, Acylated and deacylated saponins of Quillaja saponaria mixture as adjuvants for the FML-vaccine against visceral leishmaniasis, Vaccine, vol.24, issue.18, pp.3909-3920, 2006.
DOI : 10.1016/j.vaccine.2006.02.034

J. Lemesre, Methods for the culture in vitro of different stages of tissue parasites, 1994.

V. Martin, I. Vouldoukis, J. Moreno, D. Mcgahie, and S. Gueguen, The protective immune response produced in dogs after primary vaccination with the LiESP/QA-21 vaccine (CaniLeish??) remains effective against an experimental challenge one year later, Veterinary Research, vol.45, issue.1, pp.69-79, 2014.
DOI : 10.1186/1297-9716-45-69
URL : https://hal.archives-ouvertes.fr/hal-01290635

C. Costa, N. Peters, S. Maruyama, E. De-brito, . Jr et al., Vaccines for the leishmaniases: proposals for a research agenda, PLoS Negl Trop Dis, vol.5, p.21468307, 2011.

C. Palatnik-de-sousa, F. Barbosa-ade, S. Oliveira, D. Nico, and R. Bernardo, FML vaccine against canine visceral leishmaniasis: from second-generation to synthetic vaccine, Expert Review of Vaccines, vol.7, issue.6, pp.833-851, 2008.
DOI : 10.1586/14760584.7.6.833

L. Gradoni, F. Manzillo, V. Pagano, A. Piantedosi, D. et al., Failure of a multi-subunit recombinant leishmanial vaccine (MML) to protect dogs from Leishmania infantum infection and to prevent disease progression in infected animals, Vaccine, vol.23, issue.45, pp.5245-5251, 2005.
DOI : 10.1016/j.vaccine.2005.07.001

J. Poot, K. Spreeuwenberg, S. Sanderson, V. Schijns, and J. Mottram, Vaccination with a preparation based on recombinant cysteine peptidases and canine IL-12 does not protect dogs from infection with Leishmania infantum, Vaccine, vol.24, issue.14, pp.2460-2468, 2006.
DOI : 10.1016/j.vaccine.2005.12.039

O. Courtenay, R. Quinnell, L. Garcez, J. Shaw, and C. Dye, Infectiousness in a Cohort of Brazilian Dogs: Why Culling Fails to Control Visceral Leishmaniasis in Areas of High Transmission, The Journal of Infectious Diseases, vol.186, issue.9, pp.1314-1320, 2002.
DOI : 10.1086/344312

C. Keenan, L. Hendricks, L. Lightner, H. Webster, and A. Johnson, Visceral Leishmaniasis in the German Shepherd Dog. I. Infection, Clinical Disease, and Clinical Pathology, Veterinary Pathology, vol.38, issue.1, pp.74-79, 1984.
DOI : 10.1177/030098588402100113

F. Nogueira, M. Moreira, G. Borja-cabrera, F. Santos, and I. Menz, Leishmune?? vaccine blocks the transmission of canine visceral leishmaniasis, Vaccine, vol.23, issue.40, pp.4805-4810, 2005.
DOI : 10.1016/j.vaccine.2005.05.011

G. Borja-cabrera, C. Mendes, A. Paraguai-de-souza, E. , H. Okada et al., Effective immunotherapy against canine visceral leishmaniasis with the FML-vaccine, Vaccine, vol.22, issue.17-18, pp.2234-2243, 2004.
DOI : 10.1016/j.vaccine.2003.11.039

C. De-oliveira-mendes, P. De-souza, E. Borja-cabrera, G. , M. M. Batista et al., IgG1/IgG2 antibody dichotomy in sera of vaccinated or naturally infected dogs with visceral leishmaniosis, Vaccine, vol.21, issue.19-20, pp.2589-2597, 2003.
DOI : 10.1016/S0264-410X(03)00046-X

F. Santos, G. Borja-cabrera, L. Miyashiro, J. Grechi, and A. Reis, Immunotherapy against experimental canine visceral leishmaniasis with the saponin enriched-Leishmune?? vaccine, Vaccine, vol.25, issue.33, pp.6176-6190, 2007.
DOI : 10.1016/j.vaccine.2007.06.005

U. Lambertz, J. Silverman, D. Nandan, W. Mcmaster, and J. Clos, Secreted virulence factors and immune evasion in visceral leishmaniasis, Journal of Leukocyte Biology, vol.91, issue.6, pp.887-899, 2012.
DOI : 10.1189/jlb.0611326

J. Silverman, S. Chan, D. Robinson, D. Dwyer, and D. Nandan, Proteomic analysis of the secretome of Leishmania donovani, Genome Biology, vol.9, issue.2, p.18282296, 2008.
DOI : 10.1186/gb-2008-9-2-r35

M. Chenik, N. Chaabouni, B. Achour-chenik, Y. Ouakad, M. Lakhal-naouar et al., Identification of a new developmentally regulated Leishmania major large RAB GTPase, Biochemical and Biophysical Research Communications, vol.341, issue.2, pp.541-548, 2006.
DOI : 10.1016/j.bbrc.2006.01.005

L. Kahl and D. Mcmahon-pratt, Structural and antigenic characterization of a species-and promastigote-specific Leishmania mexicana amazonensis membrane protein, J Immunol, vol.138, pp.1587-1595, 1987.

I. Vouldoukis, P. Becherel, V. Riveros-moreno, M. Arock, and O. Da-silva, Interleukin-10 and interleukin-4 inhibit intracellular killing ofLeishmania infantum andLeishmania major by human macrophages by decreasing nitric oxide generation, European Journal of Immunology, vol.57, issue.4, pp.860-865, 1997.
DOI : 10.1002/eji.1830270409

E. Pinelli, D. Gebhard, A. Mommaas, M. Van-hoeij, and J. Langermans, Infection of a canine macrophage cell line with Leishmania infantum: determination of nitric oxide production and anti-leishmanial activity, Veterinary Parasitology, vol.92, issue.3, pp.181-189, 2000.
DOI : 10.1016/S0304-4017(00)00312-5

C. Mary, F. Faraut, L. Lascombe, and H. Dumon, Quantification of Leishmania infantum DNA by a Real-Time PCR Assay with High Sensitivity, Journal of Clinical Microbiology, vol.42, issue.11, pp.5249-5255, 2004.
DOI : 10.1128/JCM.42.11.5249-5255.2004

S. Bretagne, R. Durand, M. Olivi, J. Garin, and A. Sulahian, Real-Time PCR as a New Tool for Quantifying Leishmania infantum in Liver in Infected Mice, Clinical and Vaccine Immunology, vol.8, issue.4, pp.828-831, 2001.
DOI : 10.1128/CDLI.8.4.828-831.2001